Abstract
[This corrects the article DOI: 10.1155/2017/1283735.].
Highlights
Number of treated patientsName of ADM-product and its fabricant, amount of breast reconstructions (BR)/augmentations with usage of ADMs, number of patients treated with ADMs, median patient age and range in years, and median follow-up time and range in months of the given patient collective, which received a breast reconstruction/augmentation with ADM; HADM: human ADM; PADM: porcine ADM; and BADM: bovine ADM
(3) In the “Material and Methods,” the sentence reading “Sixteen patients had a history of radiotherapy prior to ADM implementation; see Table 3” should be changed to “Sixteen patients had a history of radiotherapy prior to ADM implementation; see Table 2.”
(4) In the “Discussion,” the sentence reading “Other limitations of our study include the relative brevity of followup with a mean time period of 36 months” should be changed to “Other limitations of our study include the relative brevity of follow-up with a median time period of 36 months.”
Summary
Name of ADM-product and its fabricant, amount of breast reconstructions (BR)/augmentations with usage of ADMs, number of patients treated with ADMs, median patient age and range in years, and median follow-up time and range in months of the given patient collective, which received a breast reconstruction/augmentation with ADM; HADM: human ADM; PADM: porcine ADM; and BADM: bovine ADM
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
